Eurobio Scientific Société anonyme (EPA: ALERS)

ALERS Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	203.56	203.56	190.96	162.47	126.73	110.72
Other Revenue	3	3	3.34	3.92	2.78	1.94
Revenue	206.55	206.55	194.29	166.39	129.51	112.65
Revenue Growth (YoY)	6.31%	6.31%	16.77%	28.48%	14.96%	10.67%
Cost of Revenue	78.45	78.45	73.87	60.41	50.46	44.29
Gross Profit	128.11	128.11	120.42	105.98	79.04	68.36
Selling, General & Admin	92.72	92.72	88.28	72.77	54.18	46.24
Other Operating Expenses	1.32	1.32	1.49	1.42	1.37	1.71
Operating Expenses	109.71	109.71	104.07	86.22	64.93	56.14
Operating Income	18.4	18.4	16.36	19.76	14.11	12.23
Interest Expense	-4.19	-4.19	-3.34	-2.26	-1.39	-0.72
Interest & Investment Income	1.09	1.09	0.13	-	0.02	0.03
Currency Exchange Gain (Loss)	-1.17	-1.17	0.76	0.92	0.13	-0
Other Non Operating Income (Expenses)	-0.36	-0.36	-0.35	-0.18	-0.22	0.01
EBT Excluding Unusual Items	13.78	13.78	13.55	18.25	12.67	11.54
Merger & Restructuring Charges	-1.99	-1.99	-2.97	-0.53	-1.38	-0.78
Impairment of Goodwill	-	-	-	-	0.06	-
Gain (Loss) on Sale of Assets	-0.74	-0.74	3.89	-0.01	-0.18	-0.17
Asset Writedown	0.03	0.03	-	-	-	-
Other Unusual Items	-3.61	-3.61	-0.04	-0.11	-3.98	-0.01
Pretax Income	7.45	7.45	14.44	17.6	7.19	10.58
Income Tax Expense	0.33	0.33	3.08	3.75	1.55	1.76
Earnings From Continuing Operations	-	7.13	11.35	13.86	5.64	8.82
Net Income to Company	-	7.13	11.35	13.86	5.64	8.82
Net Income	7.13	7.13	11.35	13.86	5.64	8.82
Net Income to Common	7.13	7.13	11.35	13.86	5.64	8.82
Net Income Growth	-37.23%	-37.23%	-18.08%	145.80%	-36.08%	9.23%
Shares Outstanding (Basic)	22	22	22	22	19	17
Shares Outstanding (Diluted)	22	22	22	22	19	17
Shares Change (YoY)	0.06%	0.06%	-0.41%	18.93%	10.80%	7.13%
EPS (Basic)	0.32	0.32	0.51	0.62	0.30	0.52
EPS (Diluted)	0.32	0.32	0.51	0.62	0.30	0.52
EPS Growth	-37.27%	-37.27%	-17.74%	106.67%	-42.31%	1.96%
Free Cash Flow	-4.89	-4.89	-28.02	6.47	0.75	8.19
Free Cash Flow Per Share	-0.22	-0.22	-1.26	0.29	0.04	0.48
Gross Margin	62.02%	62.02%	61.98%	63.70%	61.03%	60.68%
Operating Margin	8.91%	8.91%	8.42%	11.88%	10.90%	10.85%
Profit Margin	3.45%	3.45%	5.84%	8.33%	4.35%	7.83%
Free Cash Flow Margin	-2.37%	-2.37%	-14.42%	3.89%	0.58%	7.27%
EBITDA	23.99	23.99	30.66	31.8	23.5	20.42
EBITDA Margin	11.61%	11.61%	15.78%	19.11%	18.14%	18.12%
D&A For EBITDA	5.59	5.59	14.31	12.03	9.38	8.19
EBIT	18.4	18.4	16.36	19.76	14.11	12.23
EBIT Margin	8.91%	8.91%	8.42%	11.88%	10.90%	10.85%
Effective Tax Rate	4.39%	4.39%	21.36%	21.27%	21.60%	16.61%

Source: S&P Capital IQ. Standard template. Financial Sources.